Inventor

Jonathan R. A. Roffey

Inventor

Reading, GB

Overview

8→

Patents

2017–2021

Patent span

Chemistry

Primary field (CPC C)

Patents· 8 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%

C07DHeterocyclic compounds33%

C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium21%

A61KPreparations for medical, dental or toiletry purposes13%

PatentTitleYear

11,020,396Pyrimidinone derivatives as Cdc7 inhibitors2021 10,954,251Thienopyrimidine inhibitors of atypical protein kinase C2021 10,919,896Preparation and uses of pyrimidinone derivatives2021 10,414,763Azaquinazoline inhibitors of atypical protein kinase C2019 10,183,950Thienopyrimidine inhibitors of atypical protein kinase C2019 9,914,730'Azaquinazoline inhibitors of Atypical protein Kinase C'2018 9,896,446'Azaquinazoline inhibitors of atypical protein kinase C'2018 9,604,994'Thienopyrimidine inhibitors of atypical protein kinase C'2017

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2017–2018Patents assigned to IGNYTA INC (3)· patent assignee history

2017Patents assigned to CANCER RES TECH LTD (1)· patent assignee history

2017–2021Based in Reading, GB· patent location history

2018–2021Patents assigned to CANCER RESEARCH TECH LTD (7)· patent assignee history

2019Based in Berkshire, GB· patent location history

2021Based in Cambridge, GB· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
CANCER RESEARCH TECH LTD	7	2018–2021
IGNYTA INC	3	2017–2018
CANCER RES TECH LTD	1	2017

Locations

Location	Patents	Span
Reading, GB	5	2017–2021
Cambridge, GB	2	2021
Berkshire, GB	1	2019